RPS27A and chronic myelogenous leukemia, BCR-ABL1 positive: As the level of RPS27a expression was associated with clinical stages in CML patients in our study, it was speculated that RPS27a might be involved in the transformation of CML-CP to CML-AP/BP and implicated in the response to imatinib treatment.